Company / Working Capital
Pasithea Therapeutics Corp. Working Capital History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$32.2M
FY2022
5-year range
$32.2M / $52.9M
FY2021-FY2022
Trend
-39.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$32M in FY2022.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, working capital decreased 39.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $32.2M | -39.1% |
| FY2021 | $52.9M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026